Patient-reported experience with the Viadur 12-month leuprolide implant for prostate cancer

Urology

Volumn 58, Issue 3, 2001, Pages 430-434

  Fowler Jr, Jackson E ^a,b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN; GONADORELIN AGONIST; LEUPRORELIN; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; HUMAN; IMPLANT; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; ATTITUDE TO HEALTH; DRUG IMPLANTS; HEALTH STATUS; HUMANS; LEUPROLIDE; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SATISFACTION; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SICKNESS IMPACT PROFILE; TREATMENT OUTCOME;

EID: 0034875280     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(01)01192-X     Document Type: Article

References (21)

1. Leuprolide acetate versus diethylstilbestrol for metastatic advanced prostate cancer
2. Early results of a prospective study of hormone therapy for patients with locally advanced prostate carcinoma
3. Contemporary hormonal management of advanced prostate cancer
4. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin
5. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma; a randomized comparative trial of the Radiation Therapy Oncology Group
6. Safety and efficacy of an implantable leuprolide acetate delivery system in patients with advanced prostate cancer
7. The MOS 36-item short-form health survey (SF-36); I. Conceptual framework and item selection
8. The RAND 36-item Health Survey 1.0
9. The MOS short-form general health survey; reliability and validity in a patient population
10. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures; summary of results from the medical outcomes study
11. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill; final results
12. Norplant® implants acceptability and user satisfaction among women in two African countries
13. Patients satisfaction with a levonorgestrel-releasing contraceptive implant; reasons for and patterns of removal
14. A multicenter comparative study of the efficacy, safety and acceptability of the contraceptive subdermal implants Norplant® and Norplant®-11
15. Norplant® selection and satisfaction among low-income women
16. An analysis of testosterone implants for androgen replacement therapy
17. Treatment of hypogonadal adolescent boys with long-acting subcutaneous testosterone pellets
18. Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and fee-for-service systems; results from the medical outcomes study
19. Pain assessment after intramuscular injection
20. Patient compliance in treatment of advanced prostate cancer with luteinizing hormone-releasing hormone (LHRH) agonist